ClinVar Miner

Submissions for variant NM_000251.3(MSH2):c.2595C>T (p.Ile865=)

gnomAD frequency: 0.00001  dbSNP: rs547695133
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000216482 SCV000276842 likely benign Hereditary cancer-predisposing syndrome 2015-08-27 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV001084482 SCV000559230 likely benign Hereditary nonpolyposis colorectal neoplasms 2024-01-25 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000216482 SCV000685063 likely benign Hereditary cancer-predisposing syndrome 2017-02-12 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000679308 SCV000806034 likely benign not provided 2017-10-20 criteria provided, single submitter clinical testing
GeneDx RCV000679308 SCV001850077 likely benign not provided 2020-11-24 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000216482 SCV002534493 likely benign Hereditary cancer-predisposing syndrome 2021-12-23 criteria provided, single submitter curation
All of Us Research Program, National Institutes of Health RCV003997992 SCV004826542 likely benign Lynch syndrome 2023-11-30 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000679308 SCV001548924 likely benign not provided no assertion criteria provided clinical testing The MSH2 p.Ile865= variant was not identified in the literature nor was it identified in the Genesight-COGR, Cosmic, MutDB, UMD-LSDB, Insight Colon Cancer Gene Variant Database, Zhejiang Colon Cancer Database, Mismatch Repair Genes Variant Database, and Insight Hereditary Tumors Databases. The variant was identified in dbSNP (ID: rs547695133) as “with likely benign allele”, and in the ClinVar and Clinvitae databases as likely benign by Ambry Genetics and Invitae. Furthermore, the variant was identified in control databases in 29 of 246222 chromosomes at a frequency of 0.0001 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include and South Asian in 29 of 30774 chromosomes (freq: 0.0009), while the variant was not observed in the African, Other, Latino, European Non-Finnish, Ashkenazi Jewish, East Asian, European Finnish, populations. The p.Ile865= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.